BXPHARMA Potential Buy zone retracement before continuing upDSEBD:BXPHARMA
Beximco pharma Buy zone is approaching.
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
52.82 M USD
402.19 M USD
About Beximco Pharmaceuticals Plc
Sector
Industry
CEO
Iqbal Ahmed
Website
Headquarters
Dhaka
Founded
1976
ISIN
US0885792061
FIGI
BBG006XPRF65
Beximco Pharmaceuticals PLC engages in the business of manufacturing and marketing generic pharmaceuticals formulation products covering a wide range of therapeutic categories. Its products include solid, liquid, cream, and ointment, suppositories, metered dose inhaler, dry powder inhaler, nasal spray, sterile, lyophilized injectable, and large volume intravenous fluids. The company was founded by Ahmed Sohail Fasihur Rahman and Ahmed Salman Fasiur Rahman in 1976 and is headquartered in Dhaka, Bangladesh.
Related stocks
BEXIMCO Pharma Bleeding may end soon?DSEBD:BXPHARMA
BEXIMCO pharma is currently on major discount level & also resisting on the current support level.
Also some interesting news about the company is supporting the stock.
EPS announcement is on the door as well.
I am assuming the worst is over for DSEBD:BXPHARMA & it may regain its
See all ideas
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.